Thomas J. Schuetz Compass Therapeutics, Inc. (CMPX) insider trading activity
Thomas J. Schuetz is CHIEF EXECUTIVE OFFICER of Compass Therapeutics, Inc.. Currently has a direct ownership of 6.47 Million shares of CMPX, which is worth approximately $19.2 Million. The most recent transaction as insider was on May 17, 2022, when has been sold 20,215 shares (Common Stock) at a price of $2.47 per share, resulting in proceeds of $49,931. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
6.47M
1.52%
3M change
1.52%
12M change
Total Value Held
$19.2 Million
Thomas J. Schuetz Transaction History
TJS
Thomas J. Schuetz
CHIEF EXECUTIVE OFFICER
Boston, MA